PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa). 2012

Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan.

OBJECTIVE The translocator protein (18 kDa) (TSPO) is highly expressed on the bronchial and bronchiole epithelium, submucosal glands in intrapulmonary bronchi, pneumocytes and alveolar macrophages in human lung. This study aimed to perform positron emission tomography (PET) imaging of lung inflammation with [(18)F]FEDAC, a specific TSPO radioligand, and to determine cellular sources enriching TSPO expression in the lung. METHODS An acute lung injury model was prepared by intratracheal administration of lipopolysaccharide (LPS) to rat. Uptake of radioactivity in the rat lungs was measured with small-animal PET after injection of [(18)F]FEDAC. Presence of TSPO was examined in the lung tissue using Western blot and immunohistochemical assays. RESULTS The uptake of [(18)F]FEDAC increased in the lung with the progress of inflammation by treatment with LPS. Pretreatment with a TSPO-selective ligand PK11195 showed a significant decrease in the lung uptake of [(18)F]FEDAC due to competitive binding to TSPO. TSPO expression was elevated in the inflamed lung section and its level responded to the [(18)F]FEDAC uptake and severity of inflammation. Increase of TSPO expression was mainly found in the neutrophils and macrophages of inflamed lungs. CONCLUSIONS From this study we conclude that PET with [(18)F]FEDAC may be a useful tool for imaging TSPO expression and evaluating progress of lung inflammation. Study on human lung using [(18)F]FEDAC-PET is promising.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011650 Pulmonary Alveoli Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.

Related Publications

Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
April 2024, Annals of nuclear medicine,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
May 2024, Molecular pharmaceutics,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
August 2023, European journal of nuclear medicine and molecular imaging,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
November 2011, European journal of nuclear medicine and molecular imaging,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
July 2009, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
November 2014, Synapse (New York, N.Y.),
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
December 2021, European journal of nuclear medicine and molecular imaging,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
March 2022, Neurology,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
February 2012, Bioorganic & medicinal chemistry letters,
Akiko Hatori, and Joji Yui, and Tomoteru Yamasaki, and Lin Xie, and Katsushi Kumata, and Masayuki Fujinaga, and Yuichiro Yoshida, and Masanao Ogawa, and Nobuki Nengaki, and Kazunori Kawamura, and Toshimitsu Fukumura, and Ming-Rong Zhang
June 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Copied contents to your clipboard!